Compare CRI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRI | BHVN |
|---|---|---|
| Founded | 1865 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2002 | 2022 |
| Metric | CRI | BHVN |
|---|---|---|
| Price | $34.48 | $9.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $34.00 | $28.85 |
| AVG Volume (30 Days) | 1.3M | ★ 1.8M |
| Earning Date | 04-24-2026 | 03-02-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ 2.53 | N/A |
| Revenue | ★ $2,898,426,000.00 | N/A |
| Revenue This Year | $3.02 | N/A |
| Revenue Next Year | $0.77 | N/A |
| P/E Ratio | $13.63 | ★ N/A |
| Revenue Growth | ★ 1.91 | N/A |
| 52 Week Low | $23.38 | $7.48 |
| 52 Week High | $44.44 | $31.18 |
| Indicator | CRI | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 31.99 |
| Support Level | $31.90 | $8.40 |
| Resistance Level | $39.05 | $10.28 |
| Average True Range (ATR) | 1.75 | 0.71 |
| MACD | -0.25 | -0.13 |
| Stochastic Oscillator | 50.96 | 0.36 |
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.